NCT06406491 Passive Microprocessor-controlled Knees vs. Active Microprocessor-controlled Knees After Transfemoral Amputation
| NCT ID | NCT06406491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Median |
| Condition | Amputation |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-04-23 |
| Primary Completion | 2024-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-04-23 with a primary completion date of 2024-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates prosthetic users´ report of passive microprocessor-controlled knees (pMPK) vs. active microprocessor-controlled knees (aMPK). Outcome measurements are assessed at baseline with the pMPK and after 4 weeks of continuous use of aMPK. Measurements consists of functional outcomes, as well as patient-reported outcomes.
Eligibility Criteria
Inclusion Criteria: * transfemoral amputation or knee-disarticulation * passive microprocessor-controlled knee * resupply with new prosthesis within the next few months * K-Level 2 or 3 * body weight no more than 125 kg * German speakers Exclusion Criteria: * age less than 18 years * unable to give informed consent * body weight more than 125 kg
Contact & Investigator
Johannes Schröter, Dr. med.
PRINCIPAL INVESTIGATOR
MEDIAN Reha-Center Wiesbaden Sonnenberg
Frequently Asked Questions
Who can join the NCT06406491 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06406491 currently recruiting?
Yes, NCT06406491 is actively recruiting participants. Contact the research team at johannes.schroeter@median-kliniken.de for enrollment information.
Where is the NCT06406491 trial being conducted?
This trial is being conducted at Wiesbaden, Germany.
Who is sponsoring the NCT06406491 clinical trial?
NCT06406491 is sponsored by Median. The principal investigator is Johannes Schröter, Dr. med. at MEDIAN Reha-Center Wiesbaden Sonnenberg. The trial plans to enroll 10 participants.